Boundless Bio, Inc. (BOLD)
NASDAQ·Healthcare·Biotechnology
$1.41
+1.44%
Mkt Cap $25.52M
No analyst coverage available
We don't have analyst ratings or price target data for Boundless Bio, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.